The Gross Margin of Iovance Biotherapeutics Inc (IOVA) is 24.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 24.43% |
2023-12-31 | -804.54% |